THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE
16 October 2024
Versarien plc
("Versarien" or the "Company")
Placing to raise
Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised
The net proceeds of the Placing will be used to further increase the Company's in-house concrete and mortar testing capabilities and fund external UKAS accredited testing services for 3D construction printed products, as well as for general corporate and working capital purposes.
As announced on 14 August 2024, Versarien has signed its first significant 3D construction printing ("3DCP") contract with Building For Humanity CIC, for their flagship Charter Street project, in
As previously announced, as at 4 October 2024, the Company had a pipeline of opportunities of
Admission and Total Voting Rights
Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 22 October 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 3,718,938,737. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer |
c/o IFC |
|
|
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl |
+44 (0)20 3470 0470
|
|
|
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen |
+44 (0) 20 3934 6630 |
About Versarien:
The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.
For further information please see: http://www.versarien.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.